Power Law company profile

MacroGenics

Biotech & Life Sciences · Rockville, United States · Founded 2000 · IPO 2013 Unicorn

Developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases

Valuation

$43M

Market cap · May/2026

Revenue

$150M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

11 investors on MacroGenics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage

MPM BioImpact

InterWest Partners

Alexandria Equities

Startech Early Ventures

OrbiMed

Series B+ 6 investors entered at this stage

Alta Partners

ETP Ventures

TPG

Mithra Ventures

Ventures West

Red Abbey Venture Partners

MacroGenics mafia

Startups founded by MacroGenics alumni

Former MacroGenics employees who went on to start their own companies. Sorted by Dealroom signal score.

NextCureEst. 2015

MRMichael RichmanUnited States

Signal score68

Integrated DiagnosticsEst. 2005

Leroy HoodUnited States

Signal score57

XGraphEst. 2008

Paul MooreUnited States

Signal score55

VirobayEst. 2006

Heather PrestonUnited States

Signal score53

Book a demo to explore the full alumni network →

Global footprint

Where MacroGenics has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States99.6%

🇦🇷 Argentina0.4%

2 countries shown

Web traffic by country

9.2K monthly visits
across markets

🇺🇸 United States81.5%

🇮🇳 India12%

🇨🇦 Canada6.5%

🏳️ Russian Federation0%

Top 4 markets shown

Patent intelligence

$138M patent portfolio · 70 active families

Estimated portfolio value

$138M

322.9% of market cap · 19.8× smaller than top peer Illumina ($2.7B)

70 active patent families

Where MacroGenics innovates Human cancerCancer researchCarcinosisDiseaseMolecular biology

Where MacroGenics concentrates vs peers

Each axis is a top-10 topic across MacroGenics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about MacroGenics

An AI-synthesized read of the highest-engagement posts about MacroGenics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MacroGenics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles